SS Innovations Wins 2026 Surgical Robotics Industry Outstanding Company Award

SS Innovations International (NASDAQ: SSII) has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards. The award recognizes a company demonstrating excellence in innovation, commercial success, industry leadership, and positive societal impact. The company stated that the award reflects growing adoption of its SSi Mantra surgical robotic system, which is gaining traction for its advanced technology, user-friendly design, training capabilities, and cost efficiency.

As of June 22, 2026, SS Innovations reported that 11,719 multi-specialty procedures had been performed using the SSi Mantra system, including 612 cardiac procedures, 175 telesurgeries, and 212 pediatric surgeries. The company also noted that approximately 2,100 physicians have been trained on the platform, which has been used for more than 170 procedure types and has received regulatory approval in 14 countries. The full press release is available at https://ibn.fm/XWdRe.

SS Innovations develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible globally. The company's product range includes its proprietary SSi Mantra surgical robotic system and its suite of SSi Mudra surgical instruments, which support various procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. More information is available at ssinnovations.com.

The award underscores the company's impact on the surgical robotics industry, particularly in making advanced surgical technology more accessible. The SSi Mantra system's cost efficiency and training capabilities are key differentiators, enabling broader adoption across multiple specialties. The company's focus on telesurgery also positions it at the forefront of remote surgical care, which could expand access to expert surgical services in underserved regions.

SS Innovations continues to expand its regulatory approvals and procedure types, with 14 countries now cleared for use. The growing number of trained physicians and procedures performed suggests increasing confidence in the system's reliability and effectiveness. This award may further accelerate adoption as healthcare providers seek proven, cost-effective robotic solutions.